Sarilumab, sold under the brand name Kevzara, is a human monoclonal antibody medication against the interleukin-6 receptor. Regeneron Pharmaceuticals... 13 KB (1,182 words) - 04:42, 13 April 2024 |
 | FDA in March 2017 and is reported to cost $37,000 per year. Kevzara (sarilumab injection) is an interleukin-6 (IL-6) receptor antagonist for treatment... 26 KB (2,239 words) - 07:47, 14 April 2024 |
pathway by gefitinib tumor growth was decreased both in vitro and in vivo. Sarilumab was approved by US FDA in 2017 for rheumatoid arthritis. Several agents... 12 KB (1,289 words) - 19:20, 4 December 2023 |
Pharmaceuticals. Jevtana (Cabazitaxel), for prostate cancer. Kevzara (Sarilumab), for blood tests, lung and prostate cancer, marketed by Regeneron. Libtayo... 90 KB (8,728 words) - 08:35, 25 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 22 KB (1,841 words) - 14:41, 23 April 2024 |
Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab L04AC18 Risankizumab... 3 KB (367 words) - 15:37, 25 January 2024 |
Pegcetacoplan Ponesimod Ravulizumab Risankizumab Ritlecitinib Rozanolixizumab Sarilumab Satralizumab Siltuximab Siponimod Sirukumab Spesolimab Sutimlimab Tildrakizumab... 7 KB (271 words) - 15:59, 7 February 2024 |
saralasin (INN) sarcolysin (INN) saredutant (INN) Sarenin sargramostim (INN) sarilumab (USAN) saripidem (INN) Sarisol sarizotan (USAN) sarmazenil (INN) sarmoxicillin... 6 KB (341 words) - 15:24, 20 March 2022 |
Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 14 KB (1,017 words) - 05:42, 14 April 2024 |
 | Interleukin 6 Antibodies: ARGX-109 Clazakizumab Elsilimomab mAb 1339 Olokizumab Sarilumab Siltuximab Sirukumab Tocilizumab Levilimab IL-7 Agonists: Interleukin... 22 KB (2,577 words) - 06:53, 17 April 2024 |